Latest Articles

Publication Date
Apollo Cancer Centres Launches ‘End-O Check’ – An Early Screening and Diagnosis Program for Endometrial and Ovarian Cancers - APN News

Apollo Cancer Centres Launches ‘End-O Check’ – An Early Screening and Diagnosis Program for Endometrial and Ovarian Cancers APN News

Published: July 31, 2025, 9:37 a.m.
Early screening is vital for beating endometrial, ovarian cancers: Experts - Ahmedabad Mirror

Early screening is vital for beating endometrial, ovarian cancers: Experts Ahmedabad Mirror

Published: July 31, 2025, 1:18 a.m.
Apollo Cancer Centres Launches ‘End-O Check’ – An Early Detection and Diagnosis Program for Endometrial and Ovarian Cancers - India Education Diary

Apollo Cancer Centres Launches ‘End-O Check’ – An Early Detection and Diagnosis Program for Endometrial and Ovarian Cancers India Education Diary

Published: July 30, 2025, 12:24 p.m.
Apollo launches early screening and diagnosis programme for endometrial and ovarian cancers - BioSpectrum India

Apollo launches early screening and diagnosis programme for endometrial and ovarian cancers BioSpectrum India

Published: July 30, 2025, 11:29 a.m.
Apollo Cancer Centres Launches ‘End-O Check’ An Early Screening and Diagnosis Program for Endometrial and Ovarian Cancers - Content Media Solution

Apollo Cancer Centres Launches ‘End-O Check’ An Early Screening and Diagnosis Program for Endometrial and Ovarian Cancers Content Media Solution

Published: July 30, 2025, 10:55 a.m.
Apollo Cancer Centres Launches ‘End-O Check’ – An Early Screening and Diagnosis Program for Endometrial and Ovarian Cancers - India Education Diary

Apollo Cancer Centres Launches ‘End-O Check’ – An Early Screening and Diagnosis Program for Endometrial and Ovarian Cancers India Education Diary

Published: July 30, 2025, 10:30 a.m.
LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker.

Long interspersed element 1 (LINE-1) retrotransposons are repetitive sequences that can move within the genome by an autonomous mechanism. To limit their mutagenic potential, benign cells restrict LINE-1 expression through …

Published: March 6, 2025, midnight
Butyrate as a Potential Modulator in Gynecological Disease Progression.

This review investigates the therapeutic potential of butyrate, a short-chain fatty acid (SCFA) produced by gut microbiota, in the prevention and treatment of various gynecological diseases, including polycystic ovary syndrome …

Published: Dec. 4, 2024, midnight
Squamous Cell Carcinoma of the Ovary: A Rare Case.

Ovarian squamous cell carcinoma (SCC) is a rare entity among primary ovarian cancers. This type of cancer typically originates from the transformation of mature cystic teratomas, commonly known as dermoid …

Published: Nov. 26, 2024, midnight
Sacituzumab Tirumotecan Shows Antitumor Activity in Previously Treated Endometrial, Ovarian Cancers - OncLive

Sacituzumab Tirumotecan Shows Antitumor Activity in Previously Treated Endometrial, Ovarian Cancers OncLive

Published: Nov. 14, 2024, 8:14 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!